Abstract:Rapamycin is a triene macrolide antibiotic produced by Streptomyces hygroscopicus. Besides its wide application as an effective immunosuppressive agent, other important bioactivities have made rapamycin a potential drug lead for novel pharmaceutical development. However, the low titer of rapamycin in the original producer strain limits further industrialization efforts and restricts its use for other applications. Predicated on knowledge of the metabolic pathways related to rapamycin biosynthesis in S. hygroscopicus, we have rationally designed approaches to generate a rapamycin high producer strain of S. hygroscopicus HD-04-S. These have included alleviation of glucose repression, improved tolerance towards lysine and shikimic acid, and auxotrophy of tryptophan and phenylalanine through the application of stepwise UV mutagenesis. The resultant strain produced rapamycin at 450 mg/L in the shake flask scale. These fermentations were further scaled up in 120 and 20,000 L fermentors, respectively, at the pilot plant. Selected fermentation factors including agitation speed, pH, and on-line supplementation were systematically evaluated. A fed-batch strategy was established to maximize rapamycin production. With these efforts, an optimized fermentation process in the larger scale fermentor was developed. The final titer of rapamycin was 812 mg/L in the 120 L fermentor and 783 mg/L in the 20,000 L fermentor. This work highlights a high rapamycin producing strain derived by mutagenesis and subsequent screening, fermentation optimization of which has now made it feasible to produce rapamycin on an industrial scale by fermentation. The strategies developed here should also be applicable to titer improvement of other important microbial natural products on an industrial scale. Biotechnol. Bioeng. 2010; 107: 506-515. (C) 2010 Wiley Periodicals, Inc.

Screening of higher-yield sirolimus producer, mutant FC 904-33

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Rational screening for high production tacrolimus-producing strain

Sirolimus in 3L Fermentor

The preliminary comparison of FKBP25 in the higher sirolimus producer mutants and wild strain

Development of a yeast cell based method for efficient screening of high yield tacrolimus production strain

Screening of High Pristinamycin-Producing Strain by Combined Mutation

60Co Γ-Irradiation MUTATION INDUCTION FOR SCREENING OF AVILAMYCIN STRAINS WITH HIGH PRODUCTIVITY AND ITS CULTURE MEDIUM OPTIMIZATION

Microbial Conversion of Sirolimus by Actinoplanes Sp. ATCC 12065

Improved FK506 Production by the Precursors and Product-Tolerant Mutant of Streptomyces Tsukubaensis Based on Genome Shuffling and Dynamic Fed-Batch Strategies

Protoplast preparation of Trichoderma taxi ZJUF0986 and screening of resistant mutants

A High-Throughput Method based on Microculture Technology for Screening of High-Yield Strains of Tylosin-Producing Streptomyces fradiae

Target-site directed rational high-throughput screening system for high sophorolipids production by Candida bombicola

Enhanced Production of Sisomicin in Micromonospora inyoensis by Protoplast Mutagenesis and Fermentation Optimization

Effect of various antibiotics on the tacrolimus producing strain

Improved Neomycin Sulfate Potency in Streptomyces fradiae Using Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Fermentation Medium Optimization

Sirolimus bioconversion by Bacillus megaterium

Comparative Metabolic Profiling-Based Improvement of Rapamycin Production by Streptomyces Hygroscopicus

Isolation of high-conversion ginsenoside strain and optimization of fermentation medium

Enhancement of FK520 Production in Streptomyces Hygroscopicus by Combining Traditional Mutagenesis with Metabolic Engineering.